A Form 144 notice of proposed sale was filed on November 17, 2026, disclosing plans to sell 5,654 shares of Heartflow, Inc. common stock through the Sarah Rogers Ttee Campbell Rogers 2019 Irrevocable Trust, with the sale to be executed on NASDAQ.
Key Highlights
- Proposed sale: 5,654 shares of Heartflow, Inc. common stock, with an aggregate market value of $262,289.06, are proposed to be sold on or around November 17, 2026.
- Seller relationship: Rogers Campbell is identified as a member of the immediate family of an officer; the filing's remarks identify Campbell D. Rogers as an officer of the company and Sarah D. Rogers as his spouse and trustee of the selling trust.
- Source of shares: The 5,654 shares were acquired on March 21, 2018, via a stock option exercise from the issuer, with payment made in cash on the same date.
- Rule 10b5-1 plan: According to the filing, a trading plan or instruction was adopted on June 16, 2026.
- Shares outstanding: The filing reports 87,887,561 shares of common stock outstanding.
- Prior three-month sales: Sales reported in the preceding three months across related accounts totaled 64,141 shares with combined gross proceeds of $3,278,229.49.
Proposed Heartflow Share Sale Linked to Rogers Family Trusts and Officer Relationship
According to the Form 144 filing, the proposed sale of 5,654 shares of Heartflow, Inc. (NASDAQ:HTFL) common stock is to be conducted through Fidelity Brokerage Services LLC, located at 900 Salem Street, Smithfield, RI 02917. The filing names Rogers Campbell as the person for whose account the securities are to be sold, and identifies the relationship to the issuer as "member of immediate family of any of the foregoing." The filing's remarks clarify that "Sarah D. Rogers is a trustee and the spouse of Campbell D. Rogers, an officer of the company."
The shares proposed for sale originated from a stock option exercise on March 21, 2018, acquired directly from the issuer and paid for in cash on that same date. The filing notes that the proposed transaction relies on a Rule 10b5-1 trading plan or instruction adopted on June 16, 2026. The approximate date of sale is listed as November 17, 2026, on the NASDAQ exchange.
The filing also discloses sales made over the prior three months across multiple accounts. Campbell Rogers sold 9,219 shares on August 17, 2026, for gross proceeds of $380,099.37; 13,179 shares on September 18, 2026, for $660,926.85; and 17,430 shares on October 22, 2026, for $958,824.30. The Sarah Rogers Ttee Campbell Rogers 2019 Irrevocable Trust sold 5,653 shares on September 18, 2026, for $283,497.95 and 5,654 shares on October 22, 2026, for $311,026.54. The Sarah Rogers 2020 Irrevocable Trust sold 6,503 shares on September 18, 2026, for $326,125.45 and 6,503 shares on October 22, 2026, for $357,730.03.
What Was Disclosed
Heartflow, Inc. is the subject of a Form 144 notice proposing the sale of 5,654 common shares with an aggregate market value of $262,289.06, filed November 17, 2026, in connection with a Rule 10b5-1 plan adopted June 16, 2026, by or on behalf of Campbell D. Rogers.


Please wait processing your request...